Asset Acquisitions - Divestiture of Emerald Health Therapeutics Canada, Inc. - Narrative (Details) |
Dec. 28, 2022
USD ($)
license
$ / shares
shares
|
Dec. 31, 2023
$ / shares
|
Dec. 31, 2022
$ / shares
|
|---|---|---|---|
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
| Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | |
| Disposal Group, Disposed of by Sale, Not Discontinued Operations | Share Purchase Agreement | |||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
| Number of shares issued in transaction (in shares) | shares | 11,776,338 | ||
| Common stock, par value (in dollars per share) | $ 0 | ||
| Net proceeds from the transaction | $ | $ 110,759 | ||
| Number of licenses transferred in divestiture | license | 2 |
| X | ||||||||||
- Definition Number Of Licenses Transferred In Divestiture No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|